Does AXT (AXTI) Director’s Stock Sale Undercut Management’s Indium Phosphide Expansion Ambitions?

Simply Wall St.03-26

Earlier in March 2026, AXT Inc. reported that Director Jesse Chen had sold common stock in several open‑market transactions, reducing his directly held position by 41.43% since March 5 and leaving him...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment